TrialArthritis research & therapy2020

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.

Bernard Combe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.